Greg Downey, MD, Begins Term as President of American Thoracic Society


MAY 19, 2022

DENVER — Gregory DowneyThe American Thoracic Society (ATS) announced this week that Gregory P. Downey, MD, will serve as president for 2022-2023.  Dr. Downey is Executive Vice President of Academic Affairs and Provost at National Jewish Health, where he also serves as Professor of Medicine, Pediatrics, and Immunology and Genomic Medicine. Dr. Downey oversees all academic and research programs at National Jewish Health and holds the Drs. Harold & Mary Zirin Chair in pulmonary biology. In addition, he is professor of medicine and immunology and microbiology and associate dean of Health Affairs at the University of Colorado School of Medicine.
  

“I am honored to serve ATS in this leadership capacity,” said Dr. Downey. “I look forward to expanding the educational offerings this organization provides and to growing the ATS Research Programs as well as enhancing our strategies for disseminating new science.”

Dr. Downey’s research and clinical interests include pulmonary cell biology and acute lung injury. He has published more than 230 peer-reviewed scientific articles, editorials and book chapters, and his publications have been cited more than 20,000 times. He has received numerous honors for outstanding contributions throughout this career.

The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources.

National Jewish Health is the leading respiratory hospital in the nation. Founded 123 years ago as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune and related disorders. Patients and families come to National Jewish Health from around the world to receive cutting-edge, comprehensive, coordinated care. To learn more, visit the media resources page.



Media Resources

We have many faculty members, from bench scientists to clinicians, who can speak on almost any aspect of respiratory, immune, cardiac and gastrointestinal disease as well as lung cancer and basic immunology.

Media Contacts

Our team is available to arrange interviews, discuss events and story ideas.